169 related articles for article (PubMed ID: 29788416)
1. Evaluation of Rapid vs Standard Infliximab Infusions in the Pediatric Population.
Rozette NA; Hellauer CM; McKee C; Vazifedan T; Gabriel CA; Dice JE; Yokois NU
Inflamm Bowel Dis; 2018 Aug; 24(9):2007-2014. PubMed ID: 29788416
[TBL] [Abstract][Full Text] [Related]
2. Rapid Infliximab Infusion in Children: A Multicenter Retrospective Cohort Study.
Lev-Tzion R; Assa A; Yerushalmi B; Lahad A; Friedman M; Ledder O; Turner D
J Pediatr Gastroenterol Nutr; 2017 Nov; 65(5):e101-e103. PubMed ID: 29064928
[TBL] [Abstract][Full Text] [Related]
3. Frequency of Severe Infusion Reactions Associated With Outpatient Infusion of Infliximab Without Premedications.
Hutsell SQ; Wu M; Park KT
J Pediatr Gastroenterol Nutr; 2017 Oct; 65(4):430-431. PubMed ID: 28937551
[TBL] [Abstract][Full Text] [Related]
4. Are accelerated infliximab infusions safe in patients with inflammatory bowel disease?
Bhat S; Sharma D; Doherty P; Tham TC; Caddy GR
Inflamm Bowel Dis; 2010 Nov; 16(11):1922-5. PubMed ID: 20848465
[TBL] [Abstract][Full Text] [Related]
5. Transitioning patients with inflammatory bowel disease from hospital-based to rapid home-based infliximab: A stepwise, safety and patient-orientated process towards sustainability.
Bohra A; Rizvi QA; Keung CYY; Vasudevan A; van Langenberg DR
World J Gastroenterol; 2020 Sep; 26(36):5437-5449. PubMed ID: 33024395
[TBL] [Abstract][Full Text] [Related]
6. A one-hour infusion of infliximab during maintenance therapy is safe and well tolerated: a prospective cohort study.
Lee TW; Singh R; Fedorak RN
Aliment Pharmacol Ther; 2011 Jul; 34(2):181-7. PubMed ID: 21615434
[TBL] [Abstract][Full Text] [Related]
7. Meta-analysis: rapid infliximab infusions are safe.
Neef HC; Riebschleger MP; Adler J
Aliment Pharmacol Ther; 2013 Aug; 38(4):365-76. PubMed ID: 23815183
[TBL] [Abstract][Full Text] [Related]
8. Does infliximab short infusion have a beneficial impact on the quality of life in patients with inflammatory bowel diseases? A single centre prospective evaluation.
Principi M; Losurdo G; La Fortezza RF; Lopolito P; Lovero R; Grillo S; Bringiotti R; Ierardi E; Di Leo A
J Gastrointestin Liver Dis; 2015 Jun; 24(2):165-70. PubMed ID: 26114175
[TBL] [Abstract][Full Text] [Related]
9. Safety and Tolerability of Accelerated Infliximab Infusions in Patients With Inflammatory Bowel Disease.
Ma D; Wong W; Aviado J; Rodriguez C; Wu H
Am J Gastroenterol; 2019 Feb; 114(2):352-354. PubMed ID: 30333541
[TBL] [Abstract][Full Text] [Related]
10. The Tolerability and Efficacy of Rapid Infliximab Infusions in Patients with Inflammatory Bowel Disease.
Qazi T; Shah B; El-Dib M; Farraye FA
Dig Dis Sci; 2016 Feb; 61(2):589-96. PubMed ID: 26441281
[TBL] [Abstract][Full Text] [Related]
11. A nurse-led accelerated procedure for infliximab infusion is well tolerated and effective in patients with inflammatory bowel disease.
Michielan A; Martinato M; Favarin A; Zanotto V; Caccaro R; Caruso A; Sturniolo GC; D'Incà R
Dig Liver Dis; 2015 May; 47(5):372-7. PubMed ID: 25708258
[TBL] [Abstract][Full Text] [Related]
12. Premedication Use in Preventing Acute Infliximab Infusion Reactions in Patients with Inflammatory Bowel Disease: A Single Center Cohort Study.
Gold SL; Cohen-Mekelburg S; Schneider Y; Shen N; Faggen A; Rupert A; Scherl EJ; Bosworth B; Steinlauf A
Inflamm Bowel Dis; 2017 Oct; 23(10):1882-1889. PubMed ID: 28837521
[TBL] [Abstract][Full Text] [Related]
13. Infliximab administered with shortened infusion times in a specialized IBD infusion unit: a prospective cohort study.
Van Assche G; Vermeire S; Noman M; Amant C; Weyts E; Vleminckx A; Vermeyen MJ; Rutgeerts P
J Crohns Colitis; 2010 Sep; 4(3):329-33. PubMed ID: 21122522
[TBL] [Abstract][Full Text] [Related]
14. Rapid Infliximab Infusion in Children with Inflammatory Bowel Disease: A Multicenter North American Experience.
El-Matary W; Dykes DMH; Bauman L; Elkadri A; Carroll MW; Izaguirre MR; deBruyn J; Samson CM; Crim AM; Ali S; Grossman A
Inflamm Bowel Dis; 2017 Dec; 23(12):2104-2108. PubMed ID: 29140940
[TBL] [Abstract][Full Text] [Related]
15. Premedication and infusion reactions with infliximab: results from a pediatric inflammatory bowel disease consortium.
Jacobstein DA; Markowitz JE; Kirschner BS; Ferry G; Cohen SA; Gold BD; Winter HS; Heyman MB; Baldassano RN
Inflamm Bowel Dis; 2005 May; 11(5):442-6. PubMed ID: 15867583
[TBL] [Abstract][Full Text] [Related]
16. Rapid infusion of infliximab biosimilars and the incidence and severity of infusion-related reactions in patients with inflammatory bowel disease.
Rusch C; Wood M; Kennedy AG; Tompkins BJ; Frasca JD
J Clin Pharm Ther; 2022 Nov; 47(11):1851-1857. PubMed ID: 36134561
[TBL] [Abstract][Full Text] [Related]
17. A Quality Improvement Approach to External Infliximab Infusions in Pediatric Inflammatory Bowel Disease.
Gupta SR; Crandall WV; Donegan A; Johnson M; Drobnic B; Oates M; Boyle B; Maltz RM; Dotson JL
J Pediatr Gastroenterol Nutr; 2019 Nov; 69(5):544-550. PubMed ID: 31219936
[TBL] [Abstract][Full Text] [Related]
18. Accelerated Infliximab Infusion: Safety, Factors Predicting Adverse Events, Patients' Satisfaction and Cost Analysis. A Cohort Study in IBD Patients.
Mazzuoli S; Tricarico D; Demma F; Furneri G; Guglielmi FW
PLoS One; 2016; 11(11):e0166443. PubMed ID: 27851772
[TBL] [Abstract][Full Text] [Related]
19. Prevention of acute adverse events related to infliximab infusions in pediatric patients.
Lahdenne P; Wikström AM; Aalto K; Kolho KL
Arthritis Care Res (Hoboken); 2010 Jun; 62(6):785-90. PubMed ID: 20535789
[TBL] [Abstract][Full Text] [Related]
20. Safety of Rapid Infliximab Infusions in Children: A Systematic Review.
van Wassenaer EA; van Oosterhout JPM; Daams JG; van den Berg MJM; van der Lee H; D'Haens GR; de Meij TGJ; Benninga MA; Koot BGP
J Pediatr Gastroenterol Nutr; 2020 Sep; 71(3):361-365. PubMed ID: 32558671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]